CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) experienced significant movement in its share price Wednesday afternoon. Here's a look at what happened.
What Happened: CNS Pharmaceuticals stock soared on abnormally high volume in early trading Wednesday. The move appeared to be retail driven, given that the stock was trending on various social platforms throughout the shortened trading session.
Wednesday's trading volume of about 55.7 million shares easily exceeded the stock's average volume of about 408,000, according to Benzinga Pro.
CNS Pharmaceuticals announced a strategic move to bolster its financial position through an offering of 1.425 million shares of common stock to health-focused institutional investors. The company will also offer warrants to purchase up to 1.425 million shares in a concurrent private placement. The shares were priced at $1.39 each, while the warrants were made exercisable at $1.26 per share and allow for the purchase of shares over the next five years.
The offering is expected to close on or about July 5. CNS Pharmaceuticals said it anticipates gross proceeds from the offering of approximately $1.98 million before deducting expenses.
How To Buy CNSP Stock
By now you're likely curious about how to participate in the market for CNS Pharma – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy 'fractional shares,' which allows you to own portions of stock without buying an entire share. In the case of CNS Pharma, which is trading at $1.46 as of publishing time, $100 would buy you 68.49 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to "go short" a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
Price Action: CNS Pharmaceuticals closed Wednesday up 15.9% at $1.36, according to Benzinga Pro.
オーストラリアでは、moomooの投資商品及びサービスはMoomoo Securities Australia Limitedによって提供され、オーストラリア証券投資委員会（ASIC）の管理を受けております（AFSL No. 224663）。「金融サービスガイド」、「利用規約」、「プライバシーポリシー」などの詳細は、Moomoo Securities Australia Limitedのウェブサイトhttps://www.moomoo.com/auでご確認いただけます。
オーストラリアでは、moomooの投資商品及びサービスはMoomoo Securities Australia Limitedによって提供され、オーストラリア証券投資委員会（ASIC）の管理を受けております（AFSL No. 224663）。「金融サービスガイド」、「利用規約」、「プライバシーポリシー」などの詳細は、Moomoo Securities Australia Limitedのウェブサイトhttps://www.moomoo.com/auでご確認いただけます。
CNS Pharmaceuticals announced a strategic move to bolster its financial position through an offering of 1.425 million shares of common stock to health-focused institutional investors. The company will also offer warrants to purchase up to 1.425 million shares in a concurrent private placement. The shares were priced at $1.39 each, while the warrants were made exercisable at $1.26 per share and allow for the purchase of shares over the next five years.
CNSファーマシューティカルズは、健康に焦点を当てた機関投資家に対して、1,425,000株の普通株式を提供することで、財務的なポジションを強化する戦略的な動きを発表しました。同社は、同時に1,425,000株のファーマシューティカルズの購入権証（warrants）を提供します。株式は1.39ドルで価格が決定され、ワラントは1.26ドルで行使可能になり、次の5年間で株式を購入することができます。
